Skip to content

Clinical trials

Phase 2 Arrhythmias, Cardiac trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arrhythmias, Cardiac Phase: Phase 2 Country / region: Canada Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20231
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Terminated3
Completed1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wyeth is now a wholly owned subsidiary of Pfizer3
Cardurion Pharmaceuticals, Inc.1
Hamilton Health Sciences Corporation1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Novartis Pharmaceuticals1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arrhythmias, Cardiac8
Tachycardia, Ventricular3
Arrhythmogenic Right Ventricular Dysplasia1
Atrial Fibrillation1
Death, Sudden, Cardiac1
Polymorphic Catecholaminergic Ventricular Tachycardia1
Radiation Injuries1
Syncope1
Ventricular Fibrillation1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.